Effects of reboxetine on sympathetic neuroeffector transmission in rabbit carotid artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 306, Issue 3, 2003, Pages 995-1002

  Rasmussen, Lasse E ^a   Nedergaard, Ove A ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BRETYLIUM; COCAINE; DESIPRAMINE; NORADRENALIN; PARGYLINE; PHENYLEPHRINE; POTASSIUM; REBOXETINE; TYRAMINE;

ADRENERGIC NERVE CELL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RESPONSE; CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; NEUROTRANSMISSION; NEUROTRANSMITTER UPTAKE; NONHUMAN; NORADRENALIN RELEASE; PERIPHERAL NERVOUS SYSTEM; POSTGANGLIONIC NERVE; PRIORITY JOURNAL; RABBIT; SYMPATHETIC TONE; VASOCONSTRICTION;

ANIMALS; BRETYLIUM COMPOUNDS; CAROTID ARTERIES; COCAINE; DESIPRAMINE; MORPHOLINES; NEUROEFFECTOR JUNCTION; NOREPINEPHRINE; PARGYLINE; POTASSIUM; RABBITS; SYMPATHETIC NERVOUS SYSTEM; TRITIUM;

EID: 0041932285     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.052233     Document Type: Article

References (32)

1. Buck KJ and Amara SG (1995) Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol Pharmacol 48:1030-1037.
2. Burns MJ (2000) The pharmacology and toxicology of atypical antipsychotic agents. J Toxicol Clin Toxicol 39:1-14.
3. Burrows GD, Maguire KP, and Norman TR (1998) Antidepressant efficacy and tolerability of the selective norepinephrine reuptake inhibitor reboxetine: a review. J Clin Psychiatry 59 (Suppl 14):4-7.
4. Golds PR, Przyslo FR, and Strange PG (1980) The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors. Br J Pharmacol 68:541-549.
5. 2 receptors in the brain. Nature (Lond) 269:163-165.
6. Hall H and Ögren SO (1981) Effects of antidepressant drugs on different receptors in the brain. Eur J Pharmacol 70:393-407.
7. Iversen LL (1967) The Uptake and Storage of Noradrenaline in Sympathetic Nerves, Cambridge University Press, Cambridge.
8. Jensen TJ and Nedergaard OA (1999) Modulation of norepinephrine release from sympathetic neurons of the rabbit aorta by prejunctional prostanoid receptors. J Pharmacol Exp Ther 291:7-11.
9. Maxwell RA, Ferris RM, and Burscu JE (1976) Structural requirements or inhibition of noradrenaline uptake by phenylethylamine derivatives, desipramine, cocaine and other compounds, in The Mechanism of the Neuronal and Extraneuronal Transport of Catecholamines (Paton DM ed) pp 95-153, Raven Press, New York.
10. Maxwell RA, Keenan D, Chaplin E, Roth B, and Eckhardt SB (1969) Molecular features affecting the potency of tricyclic antidepressants and structurally related compounds as inhibitors of the uptake of tritiated norepinephrine by rabbit aortic strips. J Pharmacol Exp Ther 166:320-329.
11. McCulloch MW and Story DF (1972) Antagonism of noradrenaline and histamine by desipramine in the isolated artery of the rabbit ear. Br J Pharmacol 46:140-150.
12. Melloni M, Carniel G, Torre AD, Bonsignori A, Buonamici M, Pozzi O, Ricciardi S, and Rossi AC (1984) Potential antidepressant agents. α-Aryloxy-benzyl derivatives of ethanolamine and morpholine. Eur J Med Chem 3:235-242.
13. Melloni M, Torre AD, Lazzari E, Mazzini G, and Meroni M (1985) Configurational studies on 2-[α-(2-ethoxyphenoxy)benzyl]morpholine FCE 20124. Tetrahedron 41: 1391-1399.
14. Miller DK, Wong EHF, Chesnut MD, and Dwaskin LP (2002) Functional inhibition ofmonoamine transporters and nicotinic acetylcholine receptors. J Pharmacol Exp Ther 302:687-695.
15. Nedergaard OA (1973) Cocaine-like effect of ketamine on vascular adrenergic neurones. Eur J Pharmacol 23:153-161.
16. Nedergaard OA (1986) Presynaptic α-adrenoceptor control of transmitter release from vascular sympathetic neurons in vitro, in New Aspects of the Role of Adrenoceptors in the Cardiovascular System (Grobecker H, Philippu A, and Starke K eds) pp 24-32, Springer Verlag, Berlin.
17. 3H-noradrenaline accumulation by dopexamine hydrochloride in the isolated aorta of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 340:270-273.
18. Nedergaard OA and Bevan JA (1967) Common mode of action of DMPP and bretylium on the response of vascular smooth muscle to transmitter nerve stimulation. Fed Proc 26:293.
19. Nedergaard OA and Bevan JA (1971) Neuronal and extraneuronal uptake of adrenergic transmitter in the blood vessel, in Physiology and Pharmacology of Vascular Neuroeffector Systems (Bevan JA, Furchgott RF, Maxwell RA, and Somlyo AP eds) pp 22-34, S Karger, Basel.
20. Osswald W and Guimarães S (1983) Adrenergic mechanisms in blood vessels: morphological and pharmacological aspects. Rev Physiol Biochem Pharmacol 96:53-122.
21. Rasmussen LE and Nedergaard OA (2001) Effect of reboxetine on vascular sympathetic neuroeffector transmission in rabbit carotid artery. Proc West Pharmacol Soc 44:269.
22. Rasmussen LE and Nedergaard OA (2002) Action of reboxetine on vascular sympathetic neuroeffector transmission. Pharmacologist 44 (Suppl 1):A151.
23. 3H-(-)-phenylephrine in the perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 314:237-247.
24. Riva M, Brunello N, Rovescalli AC, Galimberti R, Carfagna N, Carminati P, et al. (1989) Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: behavioural and biochemical studies. J Drug Rev 1:243-253.
25. 3H-bretylium in peripheral sympathetic nerves. Naunyn-Schmiedeberg's Arch Pharmacol 288:283-293.
26. Sánchez C and Hyttel J (1999) Comparison of the effect of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19:467-489.
27. Scates AC and Doraiswamy PM (2000) Reboxetine: a selective norepinephrine re-uptake inhibitor for the treatment of depression. Ann Pharmacother 34:1302-1312.
28. Schroeder C, Tank J, Boschmann M, Diedrich A, Sharma AM, Biaggioni I, Luft FC, and Jordan J. (2002) Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation 105:347-353.
29. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, et al. (2000) Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342:541-549.
30. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1-124.
31. Trendelenburg U (1972) Classification of sympathomimetic amines, in Catecholamines, Handbook of Experimental Pharmacology (Blaschko H and Muscholl E eds), vol 33, pp 336-362, Springer Verlag, Berlin.
32. Wong EHF, Sonders MS, Amara SG, Tinholt PM, Piercey MFP, Hoffmann WP, Hyslop DK, Franklin S, Porsolt RD, Bonsignori A, et al. (2000) Reboxetine: a pharmacologically potent, selective and specific norepinephrine reuptake inhibitor. Biol Psychiatry 47:818-829.